drugset / Trial / NCT04648891

Spasmodic Dysphonia Pain

NCT04648891

Phase 2/3 Completed 32 enrolled Mayo Clinic
RandomizedCrossoverOpen-labelTreatment

Summary

This study aims to identify adjuvant methods to improve patient comfort during in-office laryngology procedures.

Timeline

Start
2021-08-01
Primary completion
2023-07-01
Completion
2023-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 0.5 ml Subcutaneous
Subject Lidocaine Other / unclassified 2 % Subcutaneous

Indications